Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone resulted in a significantly lower rate of a composite of total worsening heart failure events and death from cardiovascular causes than placebo. (Funded by Bayer; FINEARTS-HF ClinicalTrials.gov number, NCT04435626.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2024-09-01
DOI
https://doi.org/10.1056/nejmoa2407107
Citations
581
Primary Topic
Hormonal Regulation and Hypertension
Type
article
Field-Weighted Citation Impact
207.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Eva Gonçalvesová, Sorel Goland, Sanjiv J. Shah, Clara Saldarriaga et al.
581 citations
New England Journal of Medicine
Hormonal Regulation and Hypertension
207.82
article

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Eva Gonçalvesová, Sorel Goland, Sanjiv J. Shah, Clara Saldarriaga, Mark C. Petrie, Dirk von Lewinski, Mareev VIu, Cândida Fonseca, José Francisco Kerr Saraiva, Changsheng Ma, Heikki Ukkonen, Orly Vardeny, Johann Bauersachs, Pardeep S. Jhund, Guillermo Llamas-Esperón, Gerasimos S Filippatos, Grzegorz Gajos, James Lay‐Flurrie, John J.V. McMurray, Marco Antonio Alcocer-Gamba, Morten Schou, Alasdair Henderson, Felipe A. Martínez, Faiez M. Zannad, Gerard C.M. Linssen, Bertram Pitt, Brian Claggett, Peter Kolkhof, Mikhail Kosiborod, Scott David Solomon, Richard W. Troughton, John James Atherton, Savina Nodari, Seok‐Min Kang, Kavita Sharma, Muthiah Vaduganathan, Ovidiu Chioncel, Carolyn S.P. Lam, Imran Zainal Abidin, Gustavs Latkovskis, Vojtěch Melenovský, Tzvetana Katova, Adriaan A. Voors, Vijay Chopra, Subodh Verma, Shelley R. Zieroth, Chern‐En Chiang, Jacob A. Udell, Л. Г. Воронков, Béla Péter Merkely, Naoki Sato, Ilse van Gameren, Mehmet Birhan Yılmaz, Alex Pui‐Wai Lee, Akshay S. Desai, Prabhakar Viswanathan, Michele Senni, Josep Comin-Colet, Flaviana Amarante
article en
581 citations

Abstract

In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone resulted in a significantly lower rate of a composite of total worsening heart failure events and death from cardiovascular causes than placebo. (Funded by Bayer; FINEARTS-HF ClinicalTrials.gov number, NCT04435626.).

New England Journal of MedicineVol. 391(16)
British Heart Foundation (GB)
Bayer
Openalex Percentile: Top 0%
Hormonal Regulation and Hypertension
207.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.